Lipocine Inc. - Common Stock, par value $0.0001 per share (LPCN) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2021 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
LPCN on Nasdaq
Shares outstanding
5,578,947
Price per share
$10.45
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
1,629,909
Total reported value
$13,088,240
% of total 13F portfolios
0%
Share change
+570,602
Value change
+$4,710,434
Number of holders
25
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Lipocine Inc. - Common Stock, par value $0.0001 per share (LPCN) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Squadron Capital Management LLC 9.5% +5.6% $5,549,100 +$314,100 530,000 +6% Squadron Master Fund LP 31 Dec 2025

As of 31 Dec 2025, 25 institutional investors reported holding 1,629,909 shares of Lipocine Inc. - Common Stock, par value $0.0001 per share (LPCN). This represents 29% of the company’s total 5,578,947 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Lipocine Inc. - Common Stock, par value $0.0001 per share (LPCN) together control 29% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Squadron Capital Management LLC 9.5% 530,000 0% 1.9% $4,255,900
DIADEMA PARTNERS LP 4.7% 260,939 1.2% $2,095,340
VANGUARD GROUP INC 4% 221,867 0% 0% $1,781,592
Ikarian Capital, LLC 3.6% 199,542 0.21% $1,602,322
BlackRock, Inc. 1.6% 89,272 0% 0% $716,854
Persistent Asset Partners Ltd 1.3% 70,576 0.27% $566,726
GEODE CAPITAL MANAGEMENT, LLC 1.1% 62,450 +2.2% 0% $501,544
BOOTHBAY FUND MANAGEMENT, LLC 0.98% 54,893 0.01% $440,791
RENAISSANCE TECHNOLOGIES LLC 0.67% 37,397 +3.6% 0% $300,298
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.45% 24,909 -47% 0% $200,019
STATE STREET CORP 0.33% 18,626 0% 0% $149,567
AMERIPRISE FINANCIAL INC 0.29% 16,104 0% $129,316
NORTHERN TRUST CORP 0.24% 13,160 0% 0% $105,675
DIMENSIONAL FUND ADVISORS LP 0.22% 12,140 0% 0% $97,484
JANE STREET GROUP, LLC 0.19% 10,574 0% $84,909
UBS Group AG 0.1% 5,603 +217% 0% $44,992
MORGAN STANLEY 0.01% 751 +31% 0% $6,031
CALDWELL SUTTER CAPITAL, INC. 0.01% 471 0% 0% $3,782
GROUP ONE TRADING LLC 0% 162 0% 0% $1,301
OSAIC HOLDINGS, INC. 0% 118 -95% 0% $947
HighMark Wealth Management LLC 0% 100 0% $803
FMR LLC 0% 77 +31% 0% $618
SBI Securities Co., Ltd. 0% 67 0% 0% $538
Tidemark, LLC 0% 59 0% 0% $474
BANK OF AMERICA CORP /DE/ 0% 52 +6.1% 0% $417

Institutional Holders of Lipocine Inc. - Common Stock, par value $0.0001 per share (LPCN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 1,629,909 $13,088,240 +$4,710,434 $8.03 25
2025 Q3 529,307 $1,512,291 +$2,462 $2.85 21
2025 Q2 528,456 $1,670,206 +$34,959 $3.16 18
2025 Q1 517,473 $1,645,594 +$97,947 $3.18 19
2024 Q4 486,671 $2,375,002 -$289,398 $4.88 17
2024 Q3 544,524 $2,444,950 +$9,929 $4.49 18
2024 Q2 531,604 $4,380,488 +$476,120 $8.24 18
2024 Q1 473,865 $2,464,434 -$16,115 $5.20 17
2023 Q4 483,800 $1,345,652 -$46,888 $2.78 18
2023 Q3 499,811 $1,484,978 -$7,404 $2.97 20
2023 Q2 477,372 $2,400,563 +$2,397,563 $5.03 22
2021 Q4 0 $0 -$1,090 $10.45 0
2021 Q3 1,000 $1,090 $1.09 1
2021 Q2 1,000 $1,400 $1.40 1
2021 Q1 1,000 $1,510 +$1,510 $1.51 1